Morio, Kei
Imamura, Michio
Kawakami, Yoshiiku
Nakahara, Takashi
Nagaoki, Yuko
Kawaoka, Tomokazu
Tsuge, Masataka
Hiramatsu, Akira
Aikata, Hiroshi
Hayes, Clair Nelson
Makokha, Grace Naswa
Ochi, Hidenori
Amano, Hajime
Arataki, Keiko
Moriya, Takashi
Ito, Hiroyuki
Tsuji, Keiji
Kohno, Hiroshi
Waki, Koji
Tamura, Toru
Nakamura, Toshio
Chayama, Kazuaki
,
Funding for this research was provided by:
Japan Agency for Medical Research and Development (15fk0210001h0002)
Article History
Received: 8 August 2016
Accepted: 19 October 2016
First Online: 7 November 2016
Compliance with ethical standards
:
: Kazuaki Chayama received honoraria from MSD K.K., Bristol-Meyers Squibb, Gilead Sciences and AbbVie and research funding from Dainippon Sumitomo Pharma, TORAY, Eisai, Otsuka Pharma, Mitsubishi Tanabe Pharma, Daiichi Sankyo and Bristol-Meyers Squibb. Michio Imamura received honoraria and research funding from Bristol-Meyers Squibb. Masataka Tsuge received research funding from Bristol-Meyers Squibb.
: This research is partially supported by research funding from the Research Program on Hepatitis from the Japan Agency for Medical Research and Development, AMED (Grant Number: 15fk0210001h0002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.